Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There are so many moving parts to this whole thing, I'm not sure I know what "good" news looks like right now.
For all we know Altria could say, "we're not interested in pursuing Phase II of this R&D contract," but then present an offer to buy Lexaria Nicotine next week, next month, next year... Who knows.
"We're not interested in phase II" could mean "we don't like what we see" or "we like what we see [and don't need to see any more]."
(Assuming they have to at least respond - one way or the other...) Lexaria may be able to get more money out of 'em by suing 'em for contract infringement. XD
"Hi! Soooo... It turns-out Altria straight-up forgot about this deadline..." XD
And I agree with you - I was just point it out as a possibility. Ultimately, we'll get the answer/news when we get the answer/news.
Bear in mind, though, that this doesn't preclude the possibility that Altria already responded, say, Monday night, and Lexaria files the news sometime today. (Just one example.)
Put another way: For all we know, Altria may have already responded...! (So, all this fuss about when/if Altria "will respond" may prove to be pointless. Or not. XD)
Every time I consider the possibility that Altria partners with or buys Cannadips, the entire picture - cannabis/nicotine pouches, and DehydraTECH (i.e., Lexaria) - seems to make sense.
You've got your [DehydraTECH-augmented] cannabis pouch product - i.e., "Cannadips"... And you've got your [(possibly) DehydraTECH-augmented] nicotine pouch product - i.e., "On!".
(All the "running-down the clock" I find myself ready to attribute to the sheer complexity involved in bringing those two things together under one umbrella.)
So I'm sticking to my conviction there.
Just my $0.02; and pure speculation, obviously.
Small blurb on "derp" *eyeroll* Gazette... Nice; but nothing Earth-shattering.
https://drpgazette.com/2020/10/02/ethics-group-approves-lexaria-bioscience-corp-otcmktslxrp-to-carry-out-the-study-using-cbd-to-assess-reduction-in-blood-pressure/
Nnnnnope!
(1) Altria agreed that Phase I was successfully completed, and Bunka offered that the results were positive. "Who the hell knows" why Altria might pass on subsequent phases... but the point is that any reason(s) will most likely be business related - i.e., not pointing at anything "wrong" with the tech.
(2) Bearing (1) in mind: Lexy's got plenty of other irons in the fire, and nicotine isn't the biggest one. Lexaria is/will be a pharma company - and that's where the "real" money is. No way I'm passing-up on that because Altria decides to pass for God-knows-what reason.
It goes without saying: If any such trials show appreciable improvements in bioavailability (or whatever), you better believe it'll turn some Big Pharma heads.
"Promise of revenue" does not equal "revenue", I suspect, is part of the answer.
We need revenue - as opposed to "projection" - and/or product - as opposed to "research" - and/or major commitment - as opposed to "dipping the toe in" - news.
"You can pray in one hand and shit in the other - see which one fills-up first," as the wife likes to say...
Lexaria's corporate & IP developments are great - and folks like us appreciate them readily - but many institutions can't partake (for now), and all the small fish likely just want to see the money. ("Show me the moneeeeyyy!")
All that said, it's obvious there are quite a few large irons in the fire; let's hope many - if not most - materialize. Then it'll be "hockey stick" time.
"IIIIII lllove it when a plan comes together...!"
I think it's safe to say this is all people have been waiting for when it comes to Lexaria: some indication/evidence of improving revenues.
It's going to be an interesting few quarters...!
At least they put something out in a timely fashion - i.e., [possibly] in response to yesterday's action - this time.
They are desperate to convince folks there is revenue on the horizon. *sigh*
Maybe. I really like Abundance88's observations in this regard - i.e., there may very well be an Altria-Cannadips "something" on the horizon (e.g., possible acquisition). (Explains many things, including much about the Altria-Lexaria relationship.)
Or maybe they're just desperately shouting from the rooftops: "Look - somebody using our IP is maybe going to become successful and make us some money soon!" (Subtext being: "We'll have revenue one if these days, we promise."
Who knows. *shrug*
Yup...
Very solid theory- excellent job connecting the dots Abundance88!! (IMHO)
And thanks for sharing!
An Altria acquisition of Cannadips would connect all the dots (including Lexaria Nicotine) , methinks...!
Yeah it's a real nail-biter! XD
Who knows - different strokes for different folks.
Some are extremely well-informed.
Some are helplessly ignorant.
And some have kids that need braces.
*shrug*
"Unka Bunka"!? XD
In Unka Bunka We Trust. ;D
Oh spare us Abundance88 - we all know the reason you're spinning this yarn is because you're Bunka's cousin's son's half-sister's uncle's brother, twice removed.
I mean... Why else would someone have faith in a company in which one has decided to invest??
You're so transparent...!
It's worth mentioning, I feel, that there doesn't "have to be" a RS - the vote was in favor of giving management the option to perform one "if they deem it necessary" (i.e., so they can uplist blah-blah-blah).
Practically speaking though - crucially: strictly as things stand - it looks like one will be warranted.
Big spender...!! XD
No surprise - "more R&D" news just doesn't do anything for this stock.
Yeah the market - or, this exchange in particular perhaps - doesn't seem too gung-ho on "more R&D" type news.
But if this news does indeed prompt/force Altria's hand into what the market may interpret as a "doubling-down" (i.e., strong vote of confidence)... who knows!
And that, in turn, should set things up nicely for a RS + uplist...!
Yeah - you can dick-around and drag ass aaaaaall you want... 'til someone else shows-up and expresses interest; then it's "shit or get off the pot."
Good on Lexy!
Wherever the market values "more R&D" at, I guess.
Not the news I was hoping for, admittedly; but, in the balance sure - good news. *thumb-up*
Wondering if they intend to sit on it 'til market close... *shrug*
Too many possibilities - from the mundane to the life-altering... XD
If it's significant news, the timing - i.e., immediately ahead of tomorrow's conference - would be quite serendipitous.
Could also just be a decision on the RS. We'll see.
"Time will tell," as usual. But very interesting insights regardless Abundance88... Thank you for sharing.
Thanos: "I am... inevitable."
Cannabis: "Get in line."
https://www.cnn.com/2020/08/26/us/pennsylvania-legalize-recreational-marijuana-trnd/index.html
It's all tea leaves to us mere mortals... Successful companies have strategic visions looking many years ahead.
Who knows how it's all going to play-out "eventually" - how all the pieces will end-up fitting together; but happy to be along for the ride.
At times it feels like Lexaria discovered, patented, and is pitching the lithium-ion battery at a time when the industry is trying to wrap its head around how to get the most juice out of "the mighty potato"... *sigh*